Influence of Ejection Fraction on Outcomes and Efficacy of Sacubitril/Valsartan (LCZ696) in Heart Failure with Reduced Ejection Fraction: The Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure (PARADIGM-HF) Trial.

Influence of Ejection Fraction on Outcomes and Efficacy of Sacubitril/Valsartan (LCZ696) in Heart Failure with Reduced Ejection Fraction: The Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure (PARADIGM-HF) Trial. Circ Heart Fail. 2016 Mar; 9(3):e002744.

View in: PubMed

subject areas

Aged
Aminobutyrates
Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme Inhibitors
Biphenyl Compounds
Cause of Death
Drug Combinations
Enalapril
Female
Heart Failure
Hospitalization
Humans
Male
Middle Aged
Neprilysin
Proportional Hazards Models
Prospective Studies
Protease Inhibitors
Recovery of Function
Stroke Volume
Tetrazoles
Time Factors
Treatment Outcome
Valsartan
Ventricular Function, Left

authors with profiles

Michael R. Zile